Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.345 USD | -3.93% | +9.27% | +9.27% |
Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.27% | 293M | |
+4.11% | 106B | |
+7.02% | 23.47B | |
-14.61% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.86% | 16.78B | |
+5.52% | 14.41B | |
+34.98% | 12.86B | |
+323.64% | 8.78B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Akebia Therapeutics Shares Jump Pre-Bell on FDA Approval of Anemia Treatment for Chronic Kidney Disease Dialysis Patients